Drugs / CKD-706
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07358156 | Feb → Nov 2026 expected | atopic eczema | Chong Kun Dang Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-706 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07358156 ↗ |
| Route | Subcutaneous | “One subcutaneous dose of CKD-706 in pre-filled syringe, 300 mg/2mL” NCT07358156 ↗ |